Compare CNTY & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNTY | NEPH |
|---|---|---|
| Founded | 1992 | 1997 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.1M | 45.3M |
| IPO Year | N/A | N/A |
| Metric | CNTY | NEPH |
|---|---|---|
| Price | $1.50 | $4.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $3.67 | ★ $6.00 |
| AVG Volume (30 Days) | 38.8K | ★ 45.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.20 | $33.32 |
| Revenue Next Year | $7.18 | $12.27 |
| P/E Ratio | ★ N/A | $29.56 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.23 | $1.39 |
| 52 Week High | $3.26 | $6.42 |
| Indicator | CNTY | NEPH |
|---|---|---|
| Relative Strength Index (RSI) | 44.23 | 43.96 |
| Support Level | $1.48 | $3.67 |
| Resistance Level | $1.53 | $4.10 |
| Average True Range (ATR) | 0.05 | 0.33 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 14.41 | 36.27 |
Century Casinos Inc is a casino entertainment company that develops and operates gaming establishments as well as related lodging, restaurants, horse racing (including off-track betting), and entertainment facilities in North America. The company has three reportable segments based on the geographical locations in which its casinos operate; United States; Century Casino & Hotel-Central City, and Century Casino & Hotel-Cripple Creek in Colorado, Mountaineer Casino, Racetrack & Resort in West Virginia, and Century Casino Caruthersville, and Century Casino Cape Girardeau in Missouri, Canada; Century Casino & Hotel, Century Casino St. Albert, Century Mile Racetrack in Edmonton and Casino Century Downs Racetrack and Casino in Calgary, and Poland; Casinos Poland.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.